/IQVIA%20Holdings%20Inc%20phone%20and%20site-%20by%20T_Schneider%20via%20Shutterstock.jpg)
Durham, North Carolina-based IQVIA Holdings Inc. (IQV) provides advanced analytics, technology solutions, and clinical research services to the life sciences industry. It operates through Technology & Analytics Solutions (TAS), Research & Development Solutions (RDS), and Contract Sales & Medical Solutions (CSM) segments. With a market cap of $43.1 billion, IQVIA’s operations span the Americas, Europe, Africa, and the Indo-Pacific. It is expected to release its Q3 earnings before the market opens on Thursday, Oct. 31.
Ahead of the event, analysts expect IQVIA to report a profit of $2.57 per share, up 12.2% from $2.29 per share reported in the year-ago quarter. The company has surpassed Wall Street’s adjusted EPS projections in each of the past four quarters. Its adjusted EPS for the last reported quarter grew 9.9% year-over-year to $2.44, exceeding the consensus estimates by 3.4%.